GSK 445A
Alternative Names: GSK445A; IngB satbilized - GSK; Ingenol-B stabilized - GSKLatest Information Update: 28 Jul 2023
At a glance
- Originator GlaxoSmithKline
- Developer GSK
- Class Anti-infectives; Ingenols; Macrocyclic compounds; Small molecules
- Mechanism of Action Protein kinase C stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Mar 2021 No recent reports of development identified for preclinical development in HIV-infections in United Kingdom (Parenteral, Infusion)
- 13 Feb 2017 Preclinical trials in HIV infections in United Kingdom before February 2017
- 13 Feb 2017 Pharmacodynamics data and adverse events from preclinical studies in HIV infections presented at the 24th Conference on Retroviruses and Opportunistic Infection